Your browser doesn't support javascript.
loading
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.
Helland, Thomas; Henne, Nina; Bifulco, Ersilia; Naume, Bjørn; Borgen, Elin; Kristensen, Vessela N; Kvaløy, Jan T; Lash, Timothy L; Alnæs, Grethe I G; van Schaik, Ron H; Janssen, Emiel A M; Hustad, Steinar; Lien, Ernst A; Mellgren, Gunnar; Søiland, Håvard.
Afiliação
  • Helland T; Hormone Laboratory, Haukeland University Hospital, Bergen, Norway.
  • Henne N; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Bifulco E; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Naume B; Core Facility for Metabolomics, University of Bergen, Bergen, Norway.
  • Borgen E; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Kristensen VN; Core Facility for Metabolomics, University of Bergen, Bergen, Norway.
  • Kvaløy JT; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
  • Lash TL; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Alnæs GIG; Pathology Department, Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • van Schaik RH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Janssen EAM; Department of Mathematics and Natural Science, University of Stavanger, Stavanger, Norway.
  • Hustad S; Department of Research, Stavanger University Hospital, Stavanger, Norway.
  • Lien EA; Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, USA.
  • Mellgren G; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Søiland H; Expert Center Pharmacogenetics, Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
Breast Cancer Res ; 19(1): 125, 2017 Nov 28.
Article em En | MEDLINE | ID: mdl-29183390

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article